Iris BioTechnologies, Inc. Stock
Stocks
IRSB
US46269V1008
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
+13.96% | -58.16% |
| 15-01-27 | Iris BioTechnologies Inc. Announces Management Appointments | CI |
| 14-11-17 | Iris BioTechnologies Inc. Announces Board Elections | CI |
| Market Cap | 3.35M 3.01M 2.75M 2.51M 4.73M 315M 4.88M 33.13M 13.21M 168M 12.59M 12.32M 531M | P/E 2014 |
-15.5x | P/E 2015 | -2.42x |
|---|---|---|---|---|---|
| Enterprise Value | 3.53M 3.17M 2.9M 2.64M 4.98M 332M 5.14M 34.92M 13.93M 177M 13.27M 12.98M 560M | EV / Sales 2014 |
-
| EV / Sales 2015 | - |
| Free-Float |
29.3% | Yield 2014 * |
-
| Yield 2015 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +13.96% | - | - | 961K | |
| -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 57.24B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 57.62B | |
| +2.39% | +1.60% | +28.81% | +36.90% | 43.65B | |
| +5.75% | +10.49% | +23.11% | +108.61% | 44.03B | |
| +8.26% | +0.50% | +213.25% | +792.62% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | +0.34% | +3.41% | +56.47% | +146.77% | 40.44B | |
| Weighted average by Cap. | +0.13% | +2.44% | +52.17% | +139.03% |
| 2014 | 2015 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.19M -1.07M -977K -892K -1.68M -112M -1.73M -11.78M -4.7M -59.79M -4.47M -4.38M -189M | -1.17M -1.05M -962K -878K -1.65M -110M -1.71M -11.59M -4.62M -58.84M -4.4M -4.31M -186M |
| Net Debt | -292K -262K -239K -218K -411K -27.42M -424K -2.88M -1.15M -14.63M -1.1M -1.07M -46.19M | 181K 163K 149K 136K 256K 17.05M 264K 1.79M 715K 9.1M 681K 666K 28.72M |
Employees
-
- Stock Market
- Stocks
- IRSB Stock
Select your edition
All financial news and data tailored to specific country editions
